TNF and coronary artery disorder: In conclusion, our study suggests that miR-125b-mediated inhibition of the TNF-α/NF-κB pathway is crucial for the protection of EPCs in the inflammatory environment and may be a novel therapeutic target for enhancing the effectiveness of cell therapy for ischemic heart disease.